YMAB
$32.64
Y-Mabs Therapeutics
($.33)
(1.00%)
YMAB
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  ($0.67)
Revenue:  N/A
Wednesday
Feb 12
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when YMAB reports earnings?
Beat
Meet
Miss

Where is YMAB's stock price going from here?
Up
Flat
Down
Stock chart of YMAB
Analysts
Summary of analysts' recommendations for YMAB
Score
Grade
Pivots
Resistance
$34.10
$33.73
$33.18

$32.81

Support
$32.27
$31.90
$31.35
Tweet
Growth